Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Meituan multiple-tranche, dual-currency senior notes offerings
We advised Meituan on the transaction
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Shenzhen Xunce Technology HK$1.08 billion IPO
We advised Xunce on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
HashKey Holdings HK$1.6 billion IPO
We advised HashKey on its IPO and HKEX listing
Pony AI HK$6.71 billion dual primary listing on the Hong Kong Stock Exchange
We advised Pony AI on its dual primary listing on HKEX
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
Seyond Holdings HK$11.7 billion de-SPAC transaction and private placement
We advised Seyond on the transactions
Meituan multiple-tranche, dual-currency senior notes offerings
We advised Meituan on the transaction
DFZQ $300 million floating-rate bonds offering
The investment-grade bonds are due 2028
Seres HK$14.3 billion IPO
We advised Seres on its IPO and HKEX listing